Clinical trials
Completed Ovarian Neoplasms trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 4 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 4 |
| AstraZeneca | 4 |
| Takeda | 3 |
| Gynecologic Oncology Group | 2 |
| Merck Sharp & Dohme LLC | 2 |
| National Cancer Institute (NCI) | 2 |
| Amgen | 1 |
| Arcagy Research | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 33 |
| Fallopian Tube Neoplasms | 12 |
| Stomach Neoplasms | 6 |
| Carcinoma, Ovarian Epithelial | 5 |
| Breast Neoplasms | 4 |
| Peritoneal Neoplasms | 4 |
| Small Cell Lung Carcinoma | 4 |
| Triple Negative Breast Neoplasms | 4 |
| Carcinoma, Hepatocellular | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.